Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 8/2009

01.12.2009 | Original Paper

Effect of iron overload on exercise capacity in thalassemic patients with heart failure

verfasst von: Sophie Mavrogeni, Efstathios Gotsis, Dimitrios Verganelakis, Eleni Berdousis, Athanasios Dritsas, Genovefa Kolovou, Panagiotis Toulas, Vassilios Ladis

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

In b-thalassemia, myocardial iron overload contributes to heart failure, despite chelation treatment. We hypothesized that myocardial T2*, an index of iron overload, influences patients’ physical activity. We assessed a thalassemic population by both cardiovascular magnetic resonance imaging (CMR) and ergospirometry test. Sixty-six thalassemic patients aged 27 (19–40) years, 30 without (NHF) and 36 with heart failure (HF), were studied. Cardiac T2* and left ventricular ejection fraction (LVEF) were evaluated using a 1.5 T system. VO2max, AT, Mets and duration of exercise by ergospirometry were also assessed. Myocardial T2* was lower in HF compared to NHF patients (14.7 ± 6.6 vs. 39 ± 2 ms, P < 0.001). LVEDV and LVESV were higher in HF group compared to NHF patients (139.9 ± 16.3 vs. 124.6 ± 20.86 ml, P < 0.01 and 94.9 ± 24 vs. 38.3 ± 10.1 ml, P < 0.001, respectively). Additionally, LVEF in HF was lower compared to NHF patients (21.3 ± 6.1% vs. 69.6 ± 3.7, P < 0.001, respectively). All exercise parameters were lower in HF compared to NHF patients (P < 0.001). Patients within the HF group were additionally analyzed according to T2* values (<10 ms). HF patients with T2* < 10 ms (n = 13) were considered as high iron overloaded (HF-H) and the rest of them (n = 23) as (HF-L). Although LVEDV, LVESV, LVEF were similar in the two subgroups, the exercise parameters were significantly lower in the HF-H group (P < 0.001). Heart T2* correlated with all exercise parameters (P < 0.001). HF thalassemic patients have reduced exercise indexes compared to non HF. Myocardial iron overload, expressed as T2*, has a direct influence on exercise capacity, independent of LV ejection fraction and functional class.
Literatur
1.
Zurück zum Zitat Sankul D, Thakerngpal K, Parcharee P (1988) Cardiac pathology in 76 thalassemic patients. Birth Defects 23:177–181 Sankul D, Thakerngpal K, Parcharee P (1988) Cardiac pathology in 76 thalassemic patients. Birth Defects 23:177–181
2.
Zurück zum Zitat Ohene-Frempong K, Schwartz E (1980) Clinical features of thalassemia. Pediatr Clin North Am 27:403–411PubMed Ohene-Frempong K, Schwartz E (1980) Clinical features of thalassemia. Pediatr Clin North Am 27:403–411PubMed
3.
Zurück zum Zitat Chrysohoou C, Panagiotakos D, Barbetseas Y et al (2004) Echocardiographic and electrocardiographic prognostic factors of heart failure in young patients with β-thalassemia major: a 10-year (1995–2004) follow-up. Int J Hematol 80:336–340CrossRefPubMed Chrysohoou C, Panagiotakos D, Barbetseas Y et al (2004) Echocardiographic and electrocardiographic prognostic factors of heart failure in young patients with β-thalassemia major: a 10-year (1995–2004) follow-up. Int J Hematol 80:336–340CrossRefPubMed
4.
Zurück zum Zitat Wacker P, Balmer-Ruedin D, Oberhansil I et al (1993) Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. Chest 103:1276–1278CrossRefPubMed Wacker P, Balmer-Ruedin D, Oberhansil I et al (1993) Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. Chest 103:1276–1278CrossRefPubMed
5.
Zurück zum Zitat Henry WL, Wiener M, Miller DR et al (1978) Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. Am J Med 64:547–555CrossRefPubMed Henry WL, Wiener M, Miller DR et al (1978) Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. Am J Med 64:547–555CrossRefPubMed
6.
Zurück zum Zitat Olson LJ, Edwards WD, McCall JT, Ilstrup DM, Gersh BJ (1987) Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol 10(6):1239–1243PubMed Olson LJ, Edwards WD, McCall JT, Ilstrup DM, Gersh BJ (1987) Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol 10(6):1239–1243PubMed
7.
Zurück zum Zitat Buja LM, Roberts WC (1971) Iron in the heart: etiology and clinical significance. Am J Med 51:209–221CrossRefPubMed Buja LM, Roberts WC (1971) Iron in the heart: etiology and clinical significance. Am J Med 51:209–221CrossRefPubMed
8.
Zurück zum Zitat Jacobs A (1980) The pathology of iron overload. In: Jacobs A, Worwood M (eds) Iron in biochemistry and medicine, II. Academic Press, New York, pp 439–452 Jacobs A (1980) The pathology of iron overload. In: Jacobs A, Worwood M (eds) Iron in biochemistry and medicine, II. Academic Press, New York, pp 439–452
9.
Zurück zum Zitat Anderson LJ, Holden S, Davies B et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171–2179CrossRefPubMed Anderson LJ, Holden S, Davies B et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171–2179CrossRefPubMed
10.
Zurück zum Zitat Barry M, Sherlock S (1971) Measurement of liver iron concentration in liver biopsy specimens. Lancet 1:100–103CrossRefPubMed Barry M, Sherlock S (1971) Measurement of liver iron concentration in liver biopsy specimens. Lancet 1:100–103CrossRefPubMed
11.
Zurück zum Zitat Mavrogeni S, Maris T, Gouliamos T et al (1998) Myocardial Iron deposition in b-thalassemia studied by magnetic resonance imaging. Int J Cardiac Imaging 14:117–122CrossRef Mavrogeni S, Maris T, Gouliamos T et al (1998) Myocardial Iron deposition in b-thalassemia studied by magnetic resonance imaging. Int J Cardiac Imaging 14:117–122CrossRef
12.
Zurück zum Zitat Johnston DL, Rice L, Vick W et al (1989) Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med 87:40–47PubMedCrossRef Johnston DL, Rice L, Vick W et al (1989) Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med 87:40–47PubMedCrossRef
13.
Zurück zum Zitat Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL (2003) Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 101(11):4632–4639CrossRefPubMed Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL (2003) Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 101(11):4632–4639CrossRefPubMed
14.
Zurück zum Zitat Brittenham GM and Badman DG (2003) Noninvasive measurement of iron: report of an NIDDK workshop. Blood 101:15–19CrossRef Brittenham GM and Badman DG (2003) Noninvasive measurement of iron: report of an NIDDK workshop. Blood 101:15–19CrossRef
15.
Zurück zum Zitat Liu P, Henkelman M, Joshi J et al (1996) Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model. Can J Cardiol 12:155–164PubMed Liu P, Henkelman M, Joshi J et al (1996) Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model. Can J Cardiol 12:155–164PubMed
16.
Zurück zum Zitat Mavrogeni S, Markussis V, Kaklamanis L et al (2005) A comparison of magnetic resonance and cardiac biopsy in the evaluation of heart iron in patients with β-thalassemia. Eur J Haematol 75:241–247CrossRefPubMed Mavrogeni S, Markussis V, Kaklamanis L et al (2005) A comparison of magnetic resonance and cardiac biopsy in the evaluation of heart iron in patients with β-thalassemia. Eur J Haematol 75:241–247CrossRefPubMed
17.
Zurück zum Zitat Mavrogeni S, Gotsis ED, Berdousi E et al (2007) Myocardial and hepatic T2* magnetic resonance evaluation in ex-thalassemic patients after bone-marrow transplantation. Int J Cardiovasc Imaging 23:739–745CrossRefPubMed Mavrogeni S, Gotsis ED, Berdousi E et al (2007) Myocardial and hepatic T2* magnetic resonance evaluation in ex-thalassemic patients after bone-marrow transplantation. Int J Cardiovasc Imaging 23:739–745CrossRefPubMed
18.
Zurück zum Zitat Mavrogeni S, Gotsis E, Ladis V, Berdousis E, Verganelakis D, Toulas P, Dennis V (2008) Cokkinos. Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major. Int J Cardiovasc Imaging 24(8):849–854CrossRefPubMed Mavrogeni S, Gotsis E, Ladis V, Berdousis E, Verganelakis D, Toulas P, Dennis V (2008) Cokkinos. Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major. Int J Cardiovasc Imaging 24(8):849–854CrossRefPubMed
19.
Zurück zum Zitat McKee PA, Castelli WP, McNamara PM et al (1971) The natural history of congestive heart failure, the Framingham study. N Engl J Med 285:1441–1446PubMed McKee PA, Castelli WP, McNamara PM et al (1971) The natural history of congestive heart failure, the Framingham study. N Engl J Med 285:1441–1446PubMed
20.
Zurück zum Zitat Olivieri NF, Nathan DG, MacMillan JH et al (1994) Survival in medically treated patients with homozygous b-thalassemia. N Engl J Med 331:574–578CrossRefPubMed Olivieri NF, Nathan DG, MacMillan JH et al (1994) Survival in medically treated patients with homozygous b-thalassemia. N Engl J Med 331:574–578CrossRefPubMed
21.
Zurück zum Zitat Pennell DJ (2005) T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 1054:373–378CrossRefPubMed Pennell DJ (2005) T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 1054:373–378CrossRefPubMed
22.
Zurück zum Zitat Leonardi B, Margossian R, Colan SD, Powell AJ (2008) Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. JACC Cardiovasc Imaging 1(5):572–578CrossRefPubMed Leonardi B, Margossian R, Colan SD, Powell AJ (2008) Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. JACC Cardiovasc Imaging 1(5):572–578CrossRefPubMed
23.
Zurück zum Zitat Scharf C, Merz T, Kiowski W, Oechslin E, Schalcher C, Brunner-La Rocca HP (2002) Noninvasive assessment of cardiac pumping capacity during exercise predicts prognosis in patients with congestive heart failure. Chest 122(4):1333–1339CrossRefPubMed Scharf C, Merz T, Kiowski W, Oechslin E, Schalcher C, Brunner-La Rocca HP (2002) Noninvasive assessment of cardiac pumping capacity during exercise predicts prognosis in patients with congestive heart failure. Chest 122(4):1333–1339CrossRefPubMed
24.
Zurück zum Zitat Riley M, Northridge DB, Henderson E, Stanford CF, Nicholls DP, Dargie HJ (1992) The use of an exponential protocol for bicycle and treadmill exercise testing in patients with chronic cardiac failure. Eur Heart J 13:1363–1367PubMed Riley M, Northridge DB, Henderson E, Stanford CF, Nicholls DP, Dargie HJ (1992) The use of an exponential protocol for bicycle and treadmill exercise testing in patients with chronic cardiac failure. Eur Heart J 13:1363–1367PubMed
25.
Zurück zum Zitat Metra M, Faggiano P, D’Aloia A, Nodari S, Gualeni A, Raccagni D, Dei Cas L (1999) Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 33(4):943–950CrossRefPubMed Metra M, Faggiano P, D’Aloia A, Nodari S, Gualeni A, Raccagni D, Dei Cas L (1999) Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 33(4):943–950CrossRefPubMed
26.
Zurück zum Zitat Yang T, Dong WQ, Kuryshev YA, Obejero-Paz C, Levy MN, Brittenham GM, Kiatchoosakun S, Kirkpatrick D, Hoit BD, Brown AM (2002) Bimodal cardiac dysfunction in an animal model of iron overload. J Lab Clin Med 140(4):263–271CrossRefPubMed Yang T, Dong WQ, Kuryshev YA, Obejero-Paz C, Levy MN, Brittenham GM, Kiatchoosakun S, Kirkpatrick D, Hoit BD, Brown AM (2002) Bimodal cardiac dysfunction in an animal model of iron overload. J Lab Clin Med 140(4):263–271CrossRefPubMed
27.
Zurück zum Zitat Leon MB, Borer JS, Bacharach SL, Green MV, Benz EJ Jr, Griffith P, Nienhuis AW (1979) Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron overload. N Engl J Med 301(21):1143–1148PubMed Leon MB, Borer JS, Bacharach SL, Green MV, Benz EJ Jr, Griffith P, Nienhuis AW (1979) Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron overload. N Engl J Med 301(21):1143–1148PubMed
28.
Zurück zum Zitat Sharandak AP, Settarova DA, Sokolov SS, Tokarev IuN (1989) Physical work capacity studied by measured physical loading in patients with hereditary hemochromatosis. Ter Arkh 61(11):120–122PubMed Sharandak AP, Settarova DA, Sokolov SS, Tokarev IuN (1989) Physical work capacity studied by measured physical loading in patients with hereditary hemochromatosis. Ter Arkh 61(11):120–122PubMed
Metadaten
Titel
Effect of iron overload on exercise capacity in thalassemic patients with heart failure
verfasst von
Sophie Mavrogeni
Efstathios Gotsis
Dimitrios Verganelakis
Eleni Berdousis
Athanasios Dritsas
Genovefa Kolovou
Panagiotis Toulas
Vassilios Ladis
Publikationsdatum
01.12.2009
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 8/2009
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-009-9491-9

Weitere Artikel der Ausgabe 8/2009

The International Journal of Cardiovascular Imaging 8/2009 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.